In vitro, METTL3 knockdown decreased m6A modification and cell proliferation and promoted cell apoptosis in TGF-β-stimulated BPH-1 cells, suggesting that METTL3 knockdown partially rectifies the imbalance between epithelial proliferation and apoptosis. Here, METTL3 is linked to benign prostatic hyperplasia.